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1. Introduction 
Tendons are soft connective tissues, which connect muscle to bone forming a musculo-
tendinous unit, whose primary function is to transmit tensile loads generated by muscles to 
move and enhance joints stability. 
Adult tendons have relatively low oxygen and nutrient requirements, low cell density, and 
poor regenerative capacity. 
The biomechanical properties of tendons are mainly attributed to the high degree of 
organization of the tendon extracellular matrix, primarily composed of collagen type I, 
arranged in triple-helical molecules bundles that have different dimensions and which are 
aligned in a parallel manner in a proteoglycan matrix (Fig. 1). 
 
 
Fig. 1. Hierarchy of tendon structure. 
Tendon injuries produce considerable morbidity and affect the quality of life, the disability 
that they cause may last for several months despite what is considered appropriate 
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management. The basic cell biology of tendons is still not fully understood, and the 
management of tendon injury poses a considerable challenge for clinicians.  
Clinical approaches to tendons rupture often involve surgical repair, which frequently 
implies working with degenerative, frayed tendon tissue, unable to sustain the rigors of 
normal activities, and may fail again. 
After an injury, the healing process in tendons results in the formation of a fibrotic scar and 
it is accompanied by an increased risk of further damage. (Longo UG et al. 2010)  
The structural, organizational, and mechanical properties of this healed tissue are 
insufficient as tendons possess a limited capacity to regenerate.(Wong JK et al. 2009) (Woo 
SL et al.2006) 
Adhesion formation after intrasynovial tendon injury poses a major clinical problem. 
Disruption of the synovial sheath at the time of the injury or surgery allows granulation 
tissue and fibroblasts from the surrounding tissue to invade the repair site. Exogenous cells 
predominate over endogenous tenocytes, allowing the surrounding tissue to attach to the 
repair site, resulting in adhesion formation. (Wong JK et al. 2009) (Woo SL et al.2006) 
Despite remodeling, the biochemical and mechanical properties of healed tendon tissue 
never match those of intact tendon. It is well demonstrated that mechanical loading plays a 
central role in tenocyte proliferation and differentiation, and that the absence of mechanical 
stimuli leads to a leak of cellular phenotype. (Wang JH 2006) (Woo SL et al.2006) 
While certain tendons can be repaired by suturing the injured tissue back together, some 
heal poorly in response to this type of surgery, necessitating the use of grafts.(Kim CW & 
Pedowitz RA 2003)  
Unfortunately, finding suitable graft material can be problematic and biological grafts have 
several drawbacks. Autografts from the patient are only available in limited amounts, they 
can induce donor site morbidity, while allografts from cadavers may cause a harmful 
response from the immune system besides also being limited in supply. In both cases, the 
graft often does not match the strength of the undamaged tissue.(Goulet F et al. 2000) 
For this reason, obtaining tendinous tissue through tissue engineering approaches becomes 
a clinical necessity.  
Tissue engineering is a multidisciplinary field that involves the application of the principles 
and methods of engineering and life sciences towards i) the fundamental understanding of 
structure-function relationships in normal and pathological mammalian tissues and ii) the 
development of biological substitutes that restore, maintain or improve tissue function.  
The goal of tissue engineering is to surpass the limitations of conventional treatments based 
on organ transplantation and biomaterial implantation. It has the potential to produce a 
supply of immunologically tolerant, 'artificial' organs and tissue substitutes that can grow 
within the patient. This should lead to a permanent solution to the damage caused to the 
organ or tissue without the need for supplementary therapies, thus making it a cost-
effective, long-term treatment.  
The tissue-engineering approach involves the combination of cells, a support biomaterial 
construct, and micro-environmental factors to induce differentiation signals into surgically 
transplantable formats and promote tissue repair, functional restoration, or both. 
The earliest clinical application of human cells in tissue engineering, started around 1980, 
was for skin tissue using fibroblasts, and keratinocytes, on a scaffold. During the last 30 
years, many innovative approaches have been proposed to reconstruct different tissues: 
skin, bone, and cartilage. The field of tendon tissue engineering is relatively unexplored due 
to the difficulty in in vitro preservation of tenocyte phenotype, and only recently has 
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mechanobiology allowed a better understanding of the fundamental role of in vitro 
mechanical stimuli in maintaining the phenotype of tendinous tissues. This chapter analyzes 
the techniques used so far for the in vitro regeneration of tendinous tissues. 
2. Scaffolds requirements for tendon tissue engineering 
The scaffold should encourage cellular recruitment and tissue ingrowth. Early in the repair 
process, the scaffold should maintain its mechanical and architectural properties to protect 
cells and the new, growing tissue from strong forces and early inflammatory events. 
Subsequently, the scaffold should be gradually reabsorbed allowing a controlled exposure 
of the regenerating tissue to the local cellular, biochemical and mechanical environment. 
This will allow the tissue to develop more naturally and function more efficiently. 
In order to avoid stress shielding, the scaffold should ideally degrade at the same rate that 
the new tissue is created. In order to ensure final clinical use, neither the scaffold nor its 
degradation products should be harmful to the surrounding tissue and they should not 
result in unresolved inflammation or other deleterious biological responses.  
The tendon tissue engineering aims to repair tendon lesions in situ by integrating 
engineered, living substitutes with their native counterparts in vivo (Fig. 2). For this 
purpose, scaffolding materials are needed, and these ideally should fulfill the following 
requirements (Liu Y et al. 2008): 
- Biodegradability with adjustable degradation rate. 
- Biocompatibility before, during and after degradation. 
- Superior mechanical properties and maintenance of mechanical strength during the 
tissue regeneration process. 
- Bio-functionality: the ability to support cell proliferation and differentiation, ECM 
secretion, and tissue formation. 
- Processability: the ability to be processed to form desired constructs of complicated 
structures and shapes 
 
 
Fig. 2. Overview of tissue engineering approaches employing cell-polymer constrcuts. 
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In response to these varied criteria, a number of scaffold materials have been examined as 
scaffolds: porcine small intestine submucosa, (Musahl V at al. 2004) (Rodeo SA et al. 2004) 
silk fibers,(Altman et GH al. 2002) (Chen J at al. 2003) (Altman GH et al. 2003) 
semitendinosus tendon (Martinek V 2002), fibronectin/fibrinogen fibres. (Ahmed Z et al. 
2000) 
In addition to these, historically, three major categories of scaffolding materials have been 
employed. These are polyesters, polysaccharides, and collagen derivatives. 
However, approaches to mimic the native extracellular matrix of tendon have limitetd to 
their inappropiate mechanical strength or the lack of cell adhesion sites. The use of an 
acellular graft may prevent the initial cell necrosis observed when autografts and allografts 
are used wich leads to the deterioration of mechanical strength following implantation. 
Natural tissue scaffolds have the advantage of preserved ECM proteins important for cell 
attachment and the desired mechanical properties. 
Natural scaffolds are composed of extracellular matrix proteins that are conserved among 
different species and wich can act as scaffolds for cell attachment, migration and 
proliferation. 
Natural scaffolds have been decellularized in order to reduce their immunogenicity, a major 
hurdle to overcome in acellular scaffolds is their capacity for recellularization and 
regeneration with cellular components in vitro or in vivo, in order to achieve optimal 
biological and biochemical functions.(Gilbert TW 2006) 
2.1 Collagen scaffolds 
Collagen derivatives have been intensively investigated for use in tendon tissue engineering 
applications. Tendon extracellular matrix are mainly composed of type I collagen, so scaffolds 
based on collagen derivatives are highly biocompatible, then collagen derivatives also exhibit 
superior bio-functionality: they better support cell adhesion and cell proliferation. 
Cells cultured in collagen gels produce extracellular matrix and align longitudinally with 
the long axis of the tissue equivalent, thereby mimicking cell alignment in ligaments in 
vivo.(Goulet F et al. 2000) (Huang D 1993)  
Fibroblasts seeded in collagen gels change their shape and orientation over time (Huang D 
1993) (Bell E at al. 1979) (Klebe RJ et al.1989) (Nishiyama T et al. 1993) and these 
organizational changes have been correlated with cell proliferation, protein synthesis, and 
matrix morphogenesis. (Ben-Ze’ev A et al. 1980) (Harris AK et al. 1981) (Maciera-Coelho A 
1971) Fibroblast-seeded collagen scaffolds have been investigated with regard to their ability 
to accommodate cell attachment, proliferation, and differentiation. (Goulet F et al. 2000), 
(Huang D 1993) (Bellincampi LD et al. 1998) (Dunn MG et al. 1995) 
Collagen gel has been reported to augment the quality of tendon repair, but collagen gel 
does not possess sufficient mechanical strength, it is often accompanied by a high-strength 
component. For instance, Awad et al. (Awad HA et al. 2003) studied collagen gels in 
combination with a polyglyconate suture for patellar tendon repair. The biomechanical 
properties of the resulting tendon tissues were significantly better than those of naturally 
healed tendons, yet still much inferior to those of uninjured tendons. 
Compared with collagen gel, collagen sponges exhibit greater mechanical competence. 
Given that collagen gels exhibit superior cell-seeding efficiency, a combination of collagen 
gels with collagen fibres or sponges represents a promising strategy. Juncosa-Melvin et al. 
(Juncosa-Melvin N et al. 2006) showed that gel–collagen sponge constructs could greatly 
enhance functional tendogenesis.  
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Another study, (Gentleman E et al. 2006) provided further evidence that a combination of 
collagen gels and sponges could bolster development of tendon-like tissue.  
Despite its superior bio-functionality and biocompatibility, remaining several limitations to 
collagen. First, its processability is limited, the degree to which collagen scaffolds can be 
characterized is restricted. Then, the mechanical strength of collagen scaffolds is much lower 
than other materials such as the polyesters.  
2.2 Polyesters scaffolds 
A vast majority of biodegradable polymers for tendon tissue engineering applications are 
polyesters, such as polyglycolic acid (PGA), polylactic acid (PLA) and their copolymer 
polylactic-coglycolic acid (PLGA).These polymers are attractive, because their degradation 
products, glycolic acid and lactic acid, are natural metabolites that are normally present in 
the human body. Moreover, their good mechanical properties and their processability 
increase their appeal. 
PLGA scaffolds have been reported to improve tendon regeneration considerably. Ouyang 
et al. (Ouyang, H.W. et al. 2003) found that knitted PLGA scaffolds augmented the tendon 
healing, both histologically and mechanically. These scaffolds facilitated production of 
collagen type I and type III fibrils and contributed to the improved mechanical properties. 
PGA was also reported as a scaffolding material, Cao et al. (Cao Y.et al. 2002) developed a 
PGA scaffold that could successfully restore the mechanical capacity of tendons in a hen 
model. Moreover, Wei et al. (Wei X. et al. 2005) found that woven PGA scaffolds were 
particularly suitable for tendon tissue engineering because they surpassed the unwoven 
PGA in mechanical performance and at the same time degraded more slowly. 
The cellular responses to these materials, as well as their individual degradation profiles, 
appear to be very different. Lu et al. (Lu HH et al. 2005) compared scaffolds based on three 
different materials, PGA, poly-Llactic acid (PLLA) and PLGA. Although the PGA-based 
scaffolds showed the highest initial strength, they suddenly lost mechanical strength owing 
to the bulk degradation profile of PGA, and this resulted in a matrix disruption and a loss of 
integrity. Regarding cellular responses, it was reported that, when using PLLA and PLGA, 
the morphology of attached cells resembled that of tendons and ligaments, whereas the best 
cell proliferation was reported for surface-modified PLLA scaffolds.  
Despite their advantages, polyesters also suffer from several limitations. First, owing to their 
hydrophobic nature, poly-a-hydroxyesters do not support a high level of cell adhesion (Wan 
YQ et al. 2003) which is the initial and crucial step to engineer functional tendons. 
Fortunately, this limitation can be overcome by means of surface modification with adhesive 
agents such as fibronectin (Qin TW et al. 2005) 
Second, although degradation products of PGA, PLA and PLGA are natural metabolites, 
they are also acidic. The presence of these metabolites in large concentrations can therefore 
give rise to significant systematic or local reactions (Bostman OM et al. 2000) 
When the sizes of scaffolds are smaller, the occurrence of such adverse biological reactions is 
greatly reduced. Therefore, in general, polyesters are more used for repair of smaller defects, 
which need smaller scaffolds. 
2.3 Polysaccharides scaffolds 
Polysaccharides have also been applied in the field of soft tissue engineering, and chitosan 
in particular has been used to regenerate tendons. 
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Chitosan, a deacetylation product of chitin, is a linear polysaccharide composed of 
randomly distributed b-(1–4)-linked D-glucosamine (the deacetylated unit) and N-acetyl-D-
glucosamine (the acetylated unit), it is hydrophilic and exhibits good cell adhesion and 
proliferation characteristics (Suh JKF & Matthew, HWT 2000) 
Moreover, the N acetylglucosamine present in chitosan is a structural feature that is also 
found in glycosaminoglycan, which is involved in many specific interactions with growth 
factors, receptors and adhesion proteins. Chitosan as a glycosaminoglycan analogue might 
therefore also exhibit similar bio-functionality. Furthermore, chitosan can create highly 
porous structures that make it especially suitable for a scaffolding material used in tendon 
tissue engineering (Kumar MNVR et al. 2004) 
The bio-functionality of chitosan, such as supporting of cellular attachment and 
proliferation, and the ability to induce cells to produce ECM has been demonstrated. In a 
study conducted by Bagnaninchi et al. (Bagnaninchi et al. 2007), porous chitosan scaffolds 
with microchannels were designed to engineer tendon tissues. 
Hyaluronan (HA) is a uniformly repetitive linear GAG composed of disaccharides of 
glucuronic acid and N-acetylglucosamine: [-b (1,4)- GlcUA- b (1,3)-GlcNAc-]n (Toole BP 
2001) It is an essential component of ECM. Anionic hyaluronan interacts with other 
macromolecules, such as link proteins and proteoglycans, to facilitate tissue morphogenesis, 
cell migration, differentiation and adhesion (Toole BP 2001), whereas cationic chitosan can 
elicit electrostatic interactions with anionic glycosaminoglycans and other negatively 
charged species. (Kumar MNVR et al. 2004) 
Hybridization of hyaluronan and chitosan is expected to augment the mechanical properties 
and bioactivities of tendon tissue engineering scaffolds. Funakoshi et al. (Funakoshi et al. 
2005a) demonstrated that scaffolds composed of hybridized chitosan–hyaluronan exhibited 
enhanced mechanical competence. In another study, Funakoshi et al. (Funakoshi et al. 
2005b) reported that the chitosan–hyaluronan scaffold improved the biomechanical 
properties of the regenerated tendon tissue in the rotator cuff and bolstered production of 
collagen type I. 
Alginate, another type of polysaccharide that can be used for hybridization with chitosan, is 
an anionic polysaccharide composed of homopolymeric regions of glucuronic acid and 
mannuronic acid interspersed with mixed sequences (M-G blocks). Because it contains D-
glucuronic acid as the main sugar residue in the repeat unit, alginate is often considered to 
have similar biological activity to glycosaminoglycans. However, owing to its anionic 
nature, cell adhesion to alginate is often unsatisfactory (Rowley JA et al. 1999) (Genes NG et 
al. 2004) 
Adding cationic chitosan to alginate would augment the bio-functionality of the scaffold 
because the ionic interactions between alginate and chitosan are expected to facilitate 
retaining and recruiting of cells and growth factors, as well as cytokines (Madihally SV & 
Matthew HWT 1999) (Hsu SH et al. 2004) 
It was reported that an alginate–chitosan hybrid scaffold showed significantly enhanced cell 
adhesion to tenocytes. (Majima et al. 2005) 
2.4 Decellularized scaffolds 
In order to be utilized successfully as a biomaterial, native extracellular matrix must first be 
decellularized to remove any allogenic cells and to prevent adverse immunological 
reactions. Native scaffolds are bioactive and promotes cellular proliferation and tissue 
ingrowth. 
www.intechopen.com
Regenerative Medicine for Tendon Regeneration and Repair:  
The Role of Bioscaffolds and Mechanical Loading 
 
375 
An ideal cell removal method would not compromise graft structure and mechanical 
properties. 
Cartmell JS & Dunn MG (Cartmell JS & Dunn MG 2000) compared the effects of three 
extraction chemicals [t-octyl-phenoxypolyethoxyethanol (Triton X-100), tri(n-
butyl)phosphate (TnBP), and sodium dodecyl sulfate (SDS)] on tendon cellularity, structure, 
nativity, and mechanical properties. 
Treatment with 1% SDS for 24 h or 1% TnBP for 48 h resulted in an acellular tendon matrix 
with retention of near normal structure and mechanical properties, cell removal using SDS 
and TnBP, suggested these treatments are potentially useful for removing cells from tendon 
allografts or xenografts without compromising the graft structure or mechanical properties. 
In order to function as a living tissue, it is essential that the acellular scaffold is 
recellularized either in vivo or in vitro prior to implantation, so that remodeling of the 
scaffold to maintain the correct ultrastructural and physical properties can occur. 
Recellularization in vitro allows for further conditioning of the graft prior to implantation, 
and hopefully a more successful outcome. 
Several approaches have been developed to reseed scaffolds that are used in tissue 
engineering, including static culture, pulsatile perfusion and centrifugal force. However, the 
recellularization in most cases was not homogenous or required large numbers of cells. 
Harrison RD Gratzer PF (Harrison RD & Gratzer PF 2005) developed a decellularized bone-
anterior cruciate ligament, demonstrating that Triton-X-and TnBP-treated ligaments were 
more receptive to cellular ingrowth than SDS-treated samples. 
Woods T & Gratzer PF (Woods T & Gratzer PF 2005) reported that TnBP treatment slightly 
decreased the collagen content of the anterior cruciate ligament, but did not alter its 
mechanical properties. 
In a study, Ingram JH et al. (Ingram JH et al. 2007) have decellularized a porcine patella 
tendon scaffold with hypotonic buffer, 0.1% (w/v) sodium dodecyl sulfate (SDS), then used 
an ultrasonication treatment in order to produce a microscopically more open porous 
matrix; cells seeded onto the fascicular scaffolds penetrated throughout the scaffold and 
remained viable after 3 weeks of culture. 
Deeken CR et al. (Deeken CR et al. 2011) decellularized the central tendon of the porcine 
diaphragm with several treatments but only 1% TnBP was effective in removing cell nuclei 
while leaving the structure and composition of the tissue intact. 
3. Cells 
An important prerequisite for current tendon engineering is the successful isolation and 
selection of functionally active cells, the cells have to retain the ability to proliferate rapidly 
in vitro to provide adequate numbers for in vivo implantation.  
The most common cell types employed are fibroblasts, tenocytes and mesenchymal stem 
cells/marrow stromal cells. (Doroski DM et al. 2007) 
The main cell type found in tendon tissue is the fibroblast, which is responsible for secreting 
and maintaining the extracellular matrix. Hence, fibroblasts are the predominant cell type 
used for tissue engineering applications. (Doroski DM et al. 2007) 
Two different fibroblast populations can be found in the tendon: the elongated tenocytes 
and the ovoid-shaped tenoblasts.(Li F et.al 2008) Elongated tenocytes proliferate well in 
culture and have optimal morphology in terms of expression of collagen type 1, which is a 
major component of normal tendons. (Li F et.al 2008) Tendon cells are usually isolated from 
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human tendon samples by tissue dissociation techniques.(Bagnaninchi PO et al. 2007) (Yao L 
et al 2006) (Cao D et al 2006) 
After two or three cell culture passages and before they lose their phenotype, they are 
seeded into collagen gels or into scaffolds at an appropriate cell density (10 6 cells/mL). 
(Bagnaninchi PO et al. 2007) (Yao L et al 2006) (Cao D et al 2006) 
Anyway the use of tenocytes have some drawbacks such as limited availability of donor 
sites for cell harvest, the requirement for lengthy in vitro culture to expand the number of 
cells, and donor-site morbidity limit the practicality of this technique. (Hankemeier S et al. 
2005) (Awad HA et al. 2000) 
Stem cells may represent the ideal source for tendon engineering.There are 2 types of stem 
cells: embryonic stem cells and adult stem cells, embryonic cells are totipotent, but their 
practical use may be limited because of ethical issues and concerns regarding cell regulation. 
Adult stem cells, also known as mesenchymal stem cells, show excellent regenerative 
capacity, the ability to proliferate rapidly in culture, and the ability to differentiate into a 
wide variety of cell types.( Gao J and Caplan AI 2003) (Alhadlaq A & Mao JJ 2004) 
(Bosnakovski D et al. 2005) (Grove JE et al. 2004)  
The ability of human marrow derived adult mesenchymal stem cells that have tendinogenic 
differentiation already has been documented in several studies: mesenchymal stem cells can 
be stimulated to differentiate into fibroblasts when exposed to mechanical stress, (Ge Z et al. 
2005) and their rates of proliferation and collagen excretion have been shown to be higher 
than those of fibroblasts, so they may be a viable alternative to fibroblasts. (Li F et.al 2008)  
The ideal source of autologous stem cells would be one that is easy to obtain, results in 
minimal patient discomfort, and provides cell numbers substantial enough to obviate 
extensive expansion in culture. 
Studies have shown that raw adipose tissue contains a population of adult stem cells that 
can differentiate into bone, fat, cartilage, or muscle in vitro.( Lee RH et al. 2004) (Zuk PA et 
al. 2001) (Lee JA et al. 2003) 
These adipose-derived stem cells are easily accessible and unlike marrow are available in 
large quantities with acceptable morbidity and discomfort associated with their harvest. 
The autologous nature of these stem cells together with their putative multipotentiality and 
ease of procurement may make these cells an excellent choice for many future tendon-
engineering strategies and cell-based therapies.( Young RG et al. 1998) 
Tissues treated with these cells showed a markedly larger crosssectional area and contained 
collagen fibers that were better aligned than those in matched controls. (Awad HA et al. 
1999) 
Compared with their matched controls the MSC-mediated repair tissue showed marked 
increases in maximum stress, modulus, and strain energy density. Morphometrically,there 
were no marked differences in microstructure between the experimental and the control sides.  
Kryger et al.( Kryger et al. 2007) compared tenocytes and mesenchymal stem cells for use in 
flexor tendon tissue engineering. They studied four candidate cell types for use in reseeding 
acellularised tendon constructs. Specifically, they compared epitenon tenocytes, tendon 
sheath fibroblasts, bone marrow-derived mesenchymal stem cells (BMSCs), and 
adipoderived mesenchymal stem cells (ASCs) with respect to their in vitro growth 
characteristics, senescence and collagen production, as well as the viability of reseeded 
constructs.( Kryger et al. 2007) They also studied the in vitro viability of tendon constructs 
after reseeding and after in vivo implantation in a clinically relevant model of rabbit flexor 
tendon grafting. Results showed that epitenon tenocytes, tendon sheath cells, bone marrow 
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and adipo-derived stem cells have similar growth characteristics and can be used to 
successfully reseed acellularized tendon grafts.( Kryger et al. 2007) Constructs using the four 
cell types were also successfully implanted in vivo and showed viability after six weeks 
following implantation. ( Kryger et al. 2007) The most relevant novel finding is that adipo-
derived mesenchymal stem cells showed higher proliferation rates at later passages when 
compared with epitenon tenocytes. adipoderived mesenchymal stem cells have been shown 
to have multipotency and may be driven toward tenocyte differentiation when seeded into 
tendon constructs and exposed to the appropriate environment and mechanical forces. ( 
Kryger et al. 2007) As confirmed by immunocytochemistry analysis, these stem cells also 
produce collagen, suggesting that they would contribute to in vivo tendon matrix 
remodeling. In conclusion, these results suggest that adipoderived mesenchymal stem cells 
have a practical advantage when compared with epitenon tenocytes and sheath fibroblasts, 
given that it is easier to harvest large amounts of fat tissue. 
4. Local delivery of growth factors and gene therapy 
Numerous growth factors that promote soft-tissue regeneration such as platelet-derived 
growth factor (PDGF), epidermal growth factor, fibroblast growth factor, insulin-like 
growth factor-I, bone morphogenetic proteins (BMPs) 2 to 7, growth and differentiation 
factors 5 to 7, and transforming growth factors 1 to 3 have been studied. (Hankemeier S et al. 
2005) (Lou J et al. 2001) (Abrahamsson SO et al. 1991) (Rickert M et al. 2001) (Wang XT 2004) 
(Hsu C & Chang J 2004). 
The results of in vitro studies have shown that growth factors can promote cell proliferation 
and protein synthesis (Fu SC et al. 2003) (Jann HW et all 1999)Injured tendons treated with 
growth factors show improved mechanical properties. (Aspenberg P & Forslund C 1999) 
(Zhang F et al. 2003) (Chan BP 2000).  
Gene therapy in tendon engineering is an attractive new approach to the treatment of 
tendon lacerations. 
The challenge is to define optimal cellular targets and to identify genes that are of 
therapeutic value and vectors that can deliver these genes with minimal side effects and 
maximal efficiency and durability.  
A variety of gene transfer techniques can be used to maintain local concentrations of growth 
factor at the repair site by continuous expression of the exogene. (Dai Q et al 2003)  
Vectors that enable the uptake and expression of genes into target cells are grouped into 
viral and nonviral. Viral vectors are viruses that are deprived of their ability to replicate and 
into which the genetic material can be inserted. These vectors are effective because host cells 
into which they introduce their genetic material form part of their normal life cycle.(Lou J et 
al. 1996) 
Nonviral vectors such as liposomes are less pathogenic because of the absence of viral 
proteins, but are less efficient than viral vectors in the transfer of DNA to cells. (Jayankura M 
et al. 2003) 
For effective tissue regeneration it is important to develop methods that will deliver genes to 
the site of tendon injury. (Lou J 2000) (Hildebrand KA et al. 2004) 
Two main strategies for gene transfer using vectors can be envisioned: (1) in vivo transfer 
with a vector that is applied directly to the relevant tissue and (2) removal of cells from the 
body, transfer of the gene in vitro, and after an additional intermediate step that involves 
culture of the cells, reintroduction into the target site. 
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Direct gene transfer is less invasive and technically easier than transfer to cells in vitro 
because treatment can be started during the acute phase of injury. One disadvantage is the 
possibility of nonspecific infection of cells that are adjacent to the injury site. This risk may 
be complicated further by the fact that owing to the amount of extracellular matrix present 
and the relative few cells, a vector with high transgenic activity is needed to transfer the 
gene effectively to enough cells in vivo. 
Furthermore BMP-12 gene transfer into a complete tendon laceration in a chicken model 
produced a 2-fold increase in tensile strength and stiffness of repaired tendons. (Lou J et al. 
2001) 
Recombinant adenovirus-expressing green fluorescent protein or BMP-13 injected into 
rabbit tendons showed efficient dosedependent transgene expression in all samples at 12 
days after injection, although lymphocytic infiltration was noticed at the injection sites with 
the highest dose of virus, suggesting that injected adenoviral vectors elicit a local 
inflammatory response.  
Although the ex vivo indirect technique includes the additional step of preparing cells and 
maintaining them in vitro, it provides a greater margin of safety because modified cells can 
be tested in vitro before administration, and viral DNA that is carried by these cells is not 
administered directly to the host cells. In addition gene transfer in vitro allows the selection 
of cells that express the trans-gene at high concentrations by using a selectable gene. 
A variety of viral vectors such as adenovirus, retrovirus, adeno-associated virus, and 
liposomes have been evaluated for their ability to deliver genes to tendon, ligament, and 
meniscal cells. (Gerich TG et al. 1997) 
Although adenovirus was the most effective vector in short-term experiments, transgene 
expression was transient; although the retrovirus gave lower initial transduction efficiencies, 
the percentage of transduced cells could be increased with a selectable marker gene. 
The transfer of PDGF-B DNA to tenocytes increased the expression of PDGF and type I 
collagen gene expression in cultured tendon cells.Bone-marrow mesenchymal cells 
transfected with BMP-12 complementary DNA are placed into muscle in nude mice induced 
a neo-tendinous tissue. (Wang XT 2004) 
Furthermore type I collagen synthesis was increased in tendon cells that were transfected 
with BMP-12 complementary DNA. Platelet-derived growth factor increased flexor tendon 
cell proliferation in vitro. (Thomopoulos S et al. 2005)  
The PDGF and insulin-like growth factor-I transduced cells stimulated collagen and DNA 
synthesis in adjacent tendon cells. (Thomopoulos S et al. 2005) 
The polymer that was seeded with tendon cells in vitro was used to repair a rotator cuff tear 
and histological studies showed that the tissue-engineered construct restored tendon with 
nearly complete repair of the tear. The restoration of normal tendon histology with 
longitudinally aligned collagen fiber bundles in the experimentally treated animals was 
shown. 
5. Tendon engineering by the application of mechanical load 
In vitro tissue development may include the application of mechanical loading to 
precondition the engineered tissue for the in vivo mechanical environment. Mechanical 
stress plays a significant role in modulating cell behavior and has driven the development of 
mechanical bioreactors for tissue engineering applications.(Ingber DE 2006) (Barkhausen T 
et al. 2003) (Brown RA et al. 1998) (Wang JH et al. 2004)  
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Tendons transmit force from the muscle to the bone and act as a buffer by absorbing 
external forces to limit muscle damage. Tendons exhibit high mechanical strength, good 
flexibility, and an optimal level of elasticity to perform their unique role. Tendons are visco-
elastic tissues that display stress relaxation and creep. The mechanical behavior of the 
constituent collagen depends on the number and types of intramolecular and intermolecular 
bonds. 
Experiments have confirmed cell growth and function would be controlled locally through 
physical distortion of the associated cells or through changes in cytoskeletal tension. 
Moreover, experimental studies have demonstrated that cultured cells can be switched 
between different fates including growth, differentiation, apoptosis, directional motility or 
different stem cell lineages, by modulating cell shape. (Barkhausen T et al. 2003) (Brown RA 
et al. 1998) (Wang JH et al. 2004) (Schulze-Tanzil G et al. 2004)  
Externally applied cyclic strain under in vitro conditions has enormous effects on various 
functions of tenocytes, such as their metabolism, proliferation, orientation and matrix 
deposition (Screen HRC et al. 2005) (Yamamoto E et al. 2005) 
Kessler et al. (Kessler et al. 2001) demonstrated that collagen fibres and tendon cells can be 
oriented along the direction of the stress and can upregulate synthesis of tissue inhibitor 
matrix metalloproteinases-1 and -3 as well as of collagen type I, the main component of 
tendinous extracellular matrix.  
It is known that cyclic strain can affect cell morphology and induce uniaxial cellular 
alignment. It was observed that cyclic strain stimulation enhanced the cellular alignment 
and changed the cellular shape.  
Other experiments have demonstrated the beneficial effects of motion and mechanical 
loading on tenocyte function. Repetitive motion increases DNA content and protein 
synthesis in human tenocytes in culture.(Almekinders LC et al. 1995) (Sharma P and 
Maffulli N. 2005) Even fifteen minutes of cyclic biaxial mechanical strain applied to human 
tenocytes, results in improved cellular proliferation.(Sharma P and Maffulli N. 2005) 
(Zeichen J et al. 2000)  
Moreover, in vitro cyclic strain allows an increased production of TGF-β, FGF and PDGF by 
human tendon fibroblasts.( Bagnaninchi PO et al. 2007) (Slutek M et al. 2001)  
Cyclic stretching of collagen type I matrix seeded with MSCs for 14 days (8 h/day) resulted 
in the formation of a tendon-like matrix. (Bagnaninchi PO et al. 2007) (Zeichen J et al. 2000)  
Expression of collagen types I and III, fibrinonectin and elastin genes was found to have 
increased when compared with nonstretched controls in which no ligament matrix was 
found. (Bagnaninchi PO et al. 2007) (Yang G et al. 2004)  
The model reproduces in vivo tendon healing by preventing differentiation of tenocytes into 
fibroblasts. 
In animal experiments, mechanical stretching has improved the tensile strength, elastic 
stiffness, weight and cross-sectional area of tendons.( Sharma P & Maffulli N 2005) (Kannus 
P et al. 1992) (Kannus P et al. 1997) These effects result from an increase in collagen and 
extracellular matrix network syntheses by tenocytes. Application of a cyclic load to 
wounded avian flexor tendons results in the migration of epitendon cells into the wound.( 
Sharma P and Maffulli N 2005) (Tanaka H et al. 1995) 
Also, Qin et al. (Qin et al. 2005) found that cyclic strain promotes cell proliferation, matrix 
deposition and increased collagen production. In another study, Juncosa-Melvin et al. 
(Juncosa-Melvin et al. 2007) showed that the application of cyclic strain elevated the gene 
expression levels of collagen type I. Finally, cyclic strain can enhance mechanical 
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competence of the regenerated tendons (Juncosa-Melvin et al. 2006). The authors of this 
study found that values for maximum force, linear stiffness, maximum stress, and linear 
modulus for repaired tendons were close to those of natural patellar tendon. In terms of 
restoration of key biomechanical parameters, these constructs appear to be the best 
engineered tendons obtained so far. 
Clinical studies have shown the benefit of early mobilization following tendon repair, and 
several postoperative mobilization protocols have been advocated.(Buckwalter JA 1996) 
(Chow JA et al 1988) (Elliot D et al. 1994) The precise mechanism by which cells respond to 
load remains to be elucidated. However, cells must respond to mechanical and chemical 
signals in a coordinated fashion. For example, intercellular communication by means of gap 
junctions is necessary to mount mitogenic and matrigenic responses in ex vivo models. ( 
Sharma P & Maffulli N 2005)  
Duration, frequencies and amplitude of loading directly influence cellular response and 
behavior in many other tissues. Understanding the physiological window for these 
parameters is critical and represents future challenges of research in tendon tissue 
engineering. 
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readers can achieve a wide vision on the new and ongoing potentials of different synthetic and engineered
biomaterials. Contributions were not selected based on a direct market or clinical interest, than on results
coming from very fundamental studies which have been mainly gathered for this book. This fact will also allow
to gain a more general view of what and how the various biomaterials can do and work for, along with the
methodologies necessary to design, develop and characterize them, without the restrictions necessarily
imposed by industrial or profit concerns. The book collects 22 chapters related to recent researches on new
materials, particularly dealing with their potential and different applications in biomedicine and clinics: from
tissue engineering to polymeric scaffolds, from bone mimetic products to prostheses, up to strategies to
manage their interaction with living cells.
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